U.S. watchdog lifts price estimate for Bluebird, Vertex/CRISPR gene…
By Bhanvi Satija July 13 (Reuters) - An influential U.S.drug pricing watchdog raised the price estimate of two experimental gene therapies from Vertex Pharmaceuticals/CRISPR Therapeutics and bluebird bio to as…